These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Comparison of Efficacy and Side Effects of Oral Baclofen Versus Tizanidine Therapy with Adjuvant Botulinum Toxin Type A in Children With Cerebral Palsy and Spastic Equinus Foot Deformity. Dai AI; Aksoy SN; Demiryürek AT J Child Neurol; 2016 Feb; 31(2):184-9. PubMed ID: 25999301 [TBL] [Abstract][Full Text] [Related]
4. [Botulinum A in the treatment of equinus dynamic spasticity in children with cerebral palsy. Preliminary study]. Mousny M; Allington N Rev Chir Orthop Reparatrice Appar Mot; 1999 May; 85(2):156-63. PubMed ID: 10392416 [TBL] [Abstract][Full Text] [Related]
5. Botulinum toxin type A injections for treatment of spastic equinus in cerebral palsy: a secondary analysis of factors predictive of favorable response. Sätilä H; Huhtala H Am J Phys Med Rehabil; 2010 Nov; 89(11):865-72. PubMed ID: 20736816 [TBL] [Abstract][Full Text] [Related]
6. Treating spastic equinus foot from cerebral palsy with botulinum toxin type A: what factors influence the results?: an analysis of 189 consecutive cases. Pascual-Pascual SI; Pascual-Castroviejo I; Ruiz PJ Am J Phys Med Rehabil; 2011 Jul; 90(7):554-63. PubMed ID: 21765274 [TBL] [Abstract][Full Text] [Related]
7. Botulinum toxin a injection into calf muscles for treatment of spastic equinus in cerebral palsy: a controlled trial comparing sonography and electric stimulation-guided injection techniques: a preliminary report. Kwon JY; Hwang JH; Kim JS Am J Phys Med Rehabil; 2010 Apr; 89(4):279-86. PubMed ID: 20068435 [TBL] [Abstract][Full Text] [Related]
8. Botulinum toxin type A for the treatment of the spastic equinus foot in cerebral palsy. Cardoso ES; Rodrigues BM; Barroso M; Menezes CJ; Lucena RS; Nora DB; Melo A Pediatr Neurol; 2006 Feb; 34(2):106-9. PubMed ID: 16458821 [TBL] [Abstract][Full Text] [Related]
9. Botulinum toxin type A and dynamic equinus in children with cerebral palsy: new indication. Better than repeat casts. Prescrire Int; 2001 Feb; 10(51):12-4. PubMed ID: 11503850 [TBL] [Abstract][Full Text] [Related]
10. Botulinum toxin type A in the management of equinus in children with cerebral palsy: an evidence-based economic evaluation. Houltram J; Noble I; Boyd RN; Corry I; Flett P; Graham HK Eur J Neurol; 2001 Nov; 8 Suppl 5():194-202. PubMed ID: 11851748 [TBL] [Abstract][Full Text] [Related]
11. Botulinum toxin type A injections into the calf muscles for treatment of spastic equinus in cerebral palsy: a randomized trial comparing single and multiple injection sites. Sätilä H; Pietikäinen T; Iisalo T; Lehtonen-Räty P; Salo M; Haataja R; Koivikko M; Autti-Rämö I Am J Phys Med Rehabil; 2008 May; 87(5):386-94. PubMed ID: 18427220 [TBL] [Abstract][Full Text] [Related]
12. The influence of botulinum toxin A injections into the calf muscles on genu recurvatum in children with cerebral palsy. Klotz MC; Wolf SI; Heitzmann D; Gantz S; Braatz F; Dreher T Clin Orthop Relat Res; 2013 Jul; 471(7):2327-32. PubMed ID: 23463290 [TBL] [Abstract][Full Text] [Related]
13. Casting Protocols Following BoNT-A Injections to Treat Spastic Hypertonia of the Triceps Surae in Children with Cerebral Palsy and Equinus Gait: A Randomized Controlled Trial. Kelly B; MacKay-Lyons M; Berryman S; Hyndman J; Wood E Phys Occup Ther Pediatr; 2019; 39(1):77-93. PubMed ID: 29771161 [TBL] [Abstract][Full Text] [Related]
14. Botulinum toxin treatment in cerebral palsy: evidence for a new treatment option. Kirschner J; Berweck S; Mall V; Korinthenberg R; Heinen F J Neurol; 2001 Apr; 248 Suppl 1():28-30. PubMed ID: 11357236 [TBL] [Abstract][Full Text] [Related]
15. Spread of botulinum neurotoxin type a at standard doses is inherent to the successful treatment of spastic equinus foot in cerebral palsy: short-term neurophysiological and clinical study. Frasson E; Dall'ora E; Bordignon M; Brigo F; Tocco P; Primon D; Didonè G; Vicentini S; Fiaschi A; Bertolasi L J Child Neurol; 2012 May; 27(5):587-93. PubMed ID: 22114218 [TBL] [Abstract][Full Text] [Related]
16. AbobotulinumtoxinA for Equinus Foot Deformity in Cerebral Palsy: A Randomized Controlled Trial. Delgado MR; Tilton A; Russman B; Benavides O; Bonikowski M; Carranza J; Dabrowski E; Dursun N; Gormley M; Jozwiak M; Matthews D; Maciag-Tymecka I; Unlu E; Pham E; Tse A; Picaut P Pediatrics; 2016 Feb; 137(2):e20152830. PubMed ID: 26812925 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of botulinum toxin therapy of spastic equinus in paediatric patients with cerebral palsy. Manganotti P; Zaina F; Falso M; Milanese F; Fiaschi A J Rehabil Med; 2007 Mar; 39(2):115-20. PubMed ID: 17351692 [TBL] [Abstract][Full Text] [Related]
18. Impact of Injection-Guiding Techniques on the Effectiveness of Botulinum Toxin for the Treatment of Focal Spasticity and Dystonia: A Systematic Review. Grigoriu AI; Dinomais M; Rémy-Néris O; Brochard S Arch Phys Med Rehabil; 2015 Nov; 96(11):2067-78.e1. PubMed ID: 25982240 [TBL] [Abstract][Full Text] [Related]
19. Repeated botulinum toxin A injections in the treatment of spastic equinus foot. Metaxiotis D; Siebel A; Doederlein L Clin Orthop Relat Res; 2002 Jan; (394):177-85. PubMed ID: 11795730 [TBL] [Abstract][Full Text] [Related]
20. Efficacy and Safety of Letibotulinum Toxin A for the Treatment of Dynamic Equinus Foot Deformity in Children with Cerebral Palsy: A Randomized Controlled Trial. Chang HJ; Hong BY; Lee SJ; Lee S; Park JH; Kwon JY Toxins (Basel); 2017 Aug; 9(8):. PubMed ID: 28820439 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]